SAINT-CLOUD. France , June 23, 2023 /PRNewswire/ -- Denis DELVAL, President and CEO of Ethypharm Group, announces the appointment of Xavier LASSERRE as Chief Commercial Officer (CCO), a position effective June 12, 2023.
Xavier LASSERRE has a solid experience and extensive knowledge in the pharmaceutical industry, especially in the European markets, both in the retail and hospital sectors.
He has a degree in Neuroscience and a diploma from the ESCP (Ecole Supérieure de Commerce de Paris). With more than 25 years of experience, he has shown remarkable leadership in various functions, significantly contributing to the success and transformation of the companies under his responsibility. Xavier's most recent position has been that of Head of Commercial Operations of the Zentiva Group, being a valued member of the Executive Committee, supervising the General Directors of the subsidiaries and export activities.
Xavier joins Ethypharm's Executive Committee and will lead the company's subsidiaries in the UK, China, France, Spain, Germany and Italy. In addition, he will oversee distribution and licensing activities, as well as Business Development functions.
"I am delighted to join Ethypharm as the new Chief Commercial Officer. Ethypharm is strongly committed to improving the lives of patients, and I look forward to contributing, along with its talented team, to the growth and success of the company. I look forward to leading the strategy business, drive market expansion, and foster collaborations to bring our valuable treatments to a greater number of patients around the world." affirms Xavier LASSERRE.
Denis DELVAL -CEO and President of the Ethypharm Group, expresses his confidence in Xavier's ability to drive the business growth of the company and states: "We are delighted to welcome Xavier to the Ethypharm Group. His extensive experience and proven track record in the industry make him an ideal person for our organization. We are confident that his talent and business experience, combined with his leadership, will significantly contribute to our continued success. We are excited about this new chapter and look forward to working together to achieve our goals and further strengthen our position in the market".
About Ethypharm
Ethypharm is a European pharmaceutical company focused on the central nervous system and intensive care. Ethypharm markets its products directly in Europe and China, and has partners in North America and the Middle East. The Group employs more than 1,500 people, mainly in Europe and China. Ethypharm works closely with authorities and healthcare professionals to ensure proper use and access to its medicines by as many people as possible.
For more information visit www.ethypharm.com and follow us on LinkedIn
Photo - https://mma.prnewswire.com/media/2099901...Logo - https://mma.prnewswire.com/media/1917067...
MediaAvril PONNELLE | Director of Communication of the Ethypharm Group | 194 Bureaux de la Colline | 92213 Saint-Cloud Cedex - Franciapresse@ethypharm.com | www.ethypharm.com
View original content: https://www.prnewswire.com/news-releases/ethypharm-anuncia-el-nombramiento-de-xavier-lasserre-como-nuevo-director-comercial-301861000.html
